অনুসন্ধান ফলাফলগুলি - Chen‐Ta Chi
- প্রদর্শন 1 - 4 ফলাফল এর 4
-
1
Lenvatinib plus pembrolizumab for systemic therapy-naïve and -experienced unresectable hepatocellular carcinoma অনুযায়ী Chi-Jung Wu, Pei‐Chang Lee, Ya‐Wen Hung, Chieh-Ju Lee, Chen‐Ta Chi, I‐Cheng Lee, Ming‐Chih Hou, Yi‐Hsiang Huang
প্রকাশিত 2022Artigo -
2
Redefining Tumor Burden in Patients with Intermediate-Stage Hepatocellular Carcinoma: The Seven-Eleven Criteria অনুযায়ী Ya-Wen Hung, I-Cheng Lee, Chen-Ta Chi, Rheun‐Chuan Lee, Chien-An Liu, Nai‐Chi Chiu, Hsuen-En Hwang, Yee Chao, Ming-Chih Hou, Yi‐Hsiang Huang
প্রকাশিত 2021Artigo -
3
-
4
Gut microbiota and metabolites associate with outcomes of immune checkpoint inhibitor–treated unresectable hepatocellular carcinoma অনুযায়ী Pei‐Chang Lee, Chi-Jung Wu, Ya‐Wen Hung, Chieh Ju Lee, Chen‐Ta Chi, I‐Cheng Lee, Yu‐Lun Kuo, Shih-Hsuan Chou, Jiing‐Chyuan Luo, Ming‐Chih Hou, Yi‐Hsiang Huang
প্রকাশিত 2022Artigo
অনুসন্ধান সাধনীগুলি:
সম্পর্কিত বিষয়
Gastroenterology
Hepatocellular carcinoma
Internal medicine
Medicine
Oncology
Biology
Cancer
Cohort
Immunology
Immunotherapy
16S ribosomal RNA
Bacteria
Biochemistry
Bioinformatics
Biomarker
Confidence interval
Feces
Firmicutes
Genetics
Gut flora
HBsAg
Hazard ratio
Hepatitis B
Hepatitis B virus
Lachnospiraceae
Lenvatinib
Microbiology
Microbiome
Multivariate analysis
Nivolumab